Angiomyolipoma (AML) is a rare benign mesenchymal tumor in the liver, which is composed of blood vessels, smooth muscle, and adipose cells. The proportion of each component varies, making a diagnosis difficult. This paper reports a case of AML in the liver without adipose tissue, mimicking a hepatocellular carcinoma (HCC), which was diagnosed by a surgical tissue biopsy. A 65-year-old woman was admitted for an evaluation of a hepatic mass that had been detected by ultrasonography. The serologic markers of viral hepatitis B and C were negative. The liver function tests and alpha fetoprotein level were within the normal limits. Magnetic resonance imaging revealed a 1.9 cm sized mass in segment 6 of the liver with early arterial enhancement and washout on the delayed phase accompanied by a rim-like enhancement, which is similar to the imaging findings of HCC. A frozen section examination during surgery indicated a hepatocellular neoplasm and suggested the possibility of HCC. On the other hand, the final pathologic diagnosis was epithelioid myoid type of AML with no adipose tissue component. The tumor cells were positive for human melanocyte B-45 and negative for cytokeratin and hepatocyte paraffin 1. This paper reports a very rare case of AML without adipose tissue in the liver mimicking HCC that was diagnosed by a surgical tissue biopsy. (Korean J Gastroenterol 2018;71:49-53) 
INTRODUCTION
Most primary tumors of the liver are hepatocellular carcinoma (HCC); benign tumors are also relatively common.
Among the benign tumors, hepatic hemangioma is most common but angiomyolipoma (AML) is relatively rare. 1 AML is a benign mesenchymal tumor composed of blood vessels, smooth muscle cells, and a varying amount of fat. 2 AML occurs most often in the kidneys, with the liver being the second most frequent site of involvement. 3 The proportion of each component vary. The tumors can be categorized according to their predominant component as mixed, lipomatous, myomatous, and angiomatous type. The mixed type is most common, which is composed of epithelioid muscle cells and mixed with islands of fat and abnormal vessels. The myomatous type is more common in the liver than the kidney. with no underlying liver disease. AML can be exacerbated by estrogens but the precise mechanism is not known. 5 The size of hepatic AML varies from 0.1 cm to 40 cm, and its morphology and histology vary. 6 The tumors are usually be- 
CASE REPORT
A 65-year-old woman, who had taken hormone therapy for total high enhancement and the delayed phase revealed iso-density (Fig. 2) . On MRI, the mass was observed as homogeneous low signal intensity in T1WI and homogenous high signal intensity in T2WI. On the Gadoxetic acid (Gd-EOB-DTPA) enhanced images, the mass showed early homogeneous high enhancement in 30 seconds, almost iso-signal intensity with liver in the 1 minute image, and homogeneous washout with rim-like high enhancement in the A B C Fig. 3 . Gadoxetic acid (Gd-EOB-DTPA) enhanced dynamic magnetic resonance imaging scan shows intense and early homogeneous enhancement of the tumor (arrow) in 30 seconds (A) and iso-signal intensity at 1 minute after injection (B), and lower signal intensity of the mass compared to the increased signal intensity of the surrounding liver at 3 minutes after injection (C). showed similar MRI findings to those in the present case. 10 In the past, this AML has been considered to be entirely benign but several reports have shown that this type of tumor can be malignant with evidence of recurrence. 11-13 fluorodeoxyglucose positron emission tomography (FDG PET)/CT is a useful tool for detecting malignant transformations. 14 A few studies have reported that the FDG PET/CT findings in patients with hepatic AML showed low FDG uptake in the tumor. On the other hand, in the case of intratumoral hemorrhage, the increased FDG uptake can be shown around the hemorrhage due to hemosiderin-laden macrophages. 15 In the present case, FDG PET/CT was not performed.
Although some imaging features may suggest AML, a definite diagnosis can only be made by a tissue biopsy.
In conclusion, hepatic AML is a rare benign mesenchymal tumor. Hepatic AML with minimal adipose tissue is rarely reported, 16, 17 and hepatic AML without any adipose tissue is extremely rare. This paper reports an unusual case of hepatic AML without adipose tissue, mimicking HCC on the imaging studies, which was finally diagnosed by a surgical resection.
